Pursuant to Regulation 30 of SEBI Listing Regulations, and further to its letter dated February 3, 2023, Aurobindo Pharma has informed that the audio recording of the earnings call on the unaudited financial results for the third quarter and nine months period ended December 31, 2022, held on February 10, 2023, at 8.30 am (IST), has been uploaded on its website on the following web-link: https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/audio-or-video-recordings/.
The above information is a part of company’s filings submitted to BSE.
